Fund profile
Tickers
MSVDX, MSVEX, MSVMX, MSVOX
Fund manager
Total assets
$2.34 mm
Liabilities
$50.30 k
Net assets
$2.29 mm
Number of holdings
41.00
41 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Lilly(Eli) & Co | 171.38 k | 294.00 shares | 7.48 | Common equity | Long | USA |
UNH Unitedhealth Group Inc | 122.14 k | 232.00 shares | 5.33 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 113.06 k | 213.00 shares | 4.94 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 112.30 k | 276.00 shares | 4.90 | Common equity | Long | USA |
ARGX Argen X SE | 106.14 k | 279.00 shares | 4.63 | Common equity | Long | Netherlands |
Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio | 104.91 k | 104.91 k shares | 4.58 | Short-term investment vehicle | Long | USA |
ISRG Intuitive Surgical Inc | 103.23 k | 306.00 shares | 4.51 | Common equity | Long | USA |
TXG 10x Genomics Inc - Ordinary Shares | 98.66 k | 1.76 k shares | 4.31 | Common equity | Long | USA |
Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio | 91.30 k | 91.30 k shares | 3.99 | Short-term investment vehicle | Long | USA |
EXAS Exact Sciences Corp. | 89.29 k | 1.21 k shares | 3.90 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 80.20 k | 419.00 shares | 3.50 | Common equity | Long | USA |
SLGC SomaLogic, Inc. | 75.90 k | 30.00 k shares | 3.31 | Common equity | Long | USA |
MXCT MaxCyte Inc | 68.34 k | 14.54 k shares | 2.98 | Common equity | Long | USA |
ZTS Zoetis Inc - Ordinary Shares | 67.11 k | 340.00 shares | 2.93 | Common equity | Long | USA |
INSP Inspire Medical Systems Inc | 65.91 k | 324.00 shares | 2.88 | Common equity | Long | USA |
ALGN Align Technology, Inc. | 57.54 k | 210.00 shares | 2.51 | Common equity | Long | USA |
IDXX Idexx Laboratories, Inc. | 52.17 k | 94.00 shares | 2.28 | Common equity | Long | USA |
WST West Pharmaceutical Services, Inc. | 50.35 k | 143.00 shares | 2.20 | Common equity | Long | USA |
VEEV Veeva Systems Inc - Ordinary Shares | 49.86 k | 259.00 shares | 2.18 | Common equity | Long | USA |
Stevanato Group SpA
|
48.93 k | 1.79 k shares | 2.14 | Common equity | Long | Italy |
NTLA Intellia Therapeutics Inc | 48.57 k | 1.59 k shares | 2.12 | Common equity | Long | USA |
ALT Altimmune Inc | 46.79 k | 4.16 k shares | 2.04 | Common equity | Long | USA |
Royalty Pharma PLC
|
44.35 k | 1.58 k shares | 1.94 | Common equity | Long | UK |
EVO Evotec SE | 40.69 k | 3.48 k shares | 1.78 | Common equity | Long | Germany |
ILMN Illumina Inc | 40.24 k | 289.00 shares | 1.76 | Common equity | Long | USA |
SDGR Schrodinger Inc | 39.31 k | 1.10 k shares | 1.72 | Common equity | Long | USA |
DOCS Doximity Inc - Ordinary Shares | 37.94 k | 1.35 k shares | 1.66 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 37.24 k | 1.37 k shares | 1.63 | Common equity | Long | USA |
MRNA Moderna Inc | 37.00 k | 372.00 shares | 1.62 | Common equity | Long | USA |
AGL Agilon Health Inc | 35.32 k | 2.81 k shares | 1.54 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 32.87 k | 261.00 shares | 1.44 | Common equity | Long | Denmark |
FDMT 4D Molecular Therapeutics Inc | 25.79 k | 1.27 k shares | 1.13 | Common equity | Long | USA |
CHWY Chewy Inc - Ordinary Shares | 23.87 k | 1.01 k shares | 1.04 | Common equity | Long | USA |
ABCL AbCellera Biologics Inc | 18.40 k | 3.22 k shares | 0.80 | Common equity | Long | Canada |
RLAY Relay Therapeutics Inc | 13.54 k | 1.23 k shares | 0.59 | Common equity | Long | USA |
ATAI Life Sciences NV
|
12.55 k | 8.90 k shares | 0.55 | Common equity | Long | Netherlands |
HSBC TRI PARTY A REPO | 6.71 k | 6.71 k principal | 0.29 | Repurchase agreement | Long | USA |
MERRILL LYNCH TRI PARTY A REPO | 6.71 k | 6.71 k principal | 0.29 | Repurchase agreement | Long | USA |
Citigroup Global Markets Inc | 6.71 k | 6.71 k principal | 0.29 | Repurchase agreement | Long | USA |
FATE Fate Therapeutics Inc | 5.88 k | 1.57 k shares | 0.26 | Common equity | Long | USA |
GH Research PLC
|
5.56 k | 958.00 shares | 0.24 | Common equity | Long | Ireland |